BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 2007
View Archived Issues
Avexa reports progress with apricitabine
Read More
NovaCal changes name to NovaBay
Read More
Plethora seeks clearance to begin phase III for PSD-502 in premature ejaculation
Read More
TorreyPines and Eisai extend Alzheimer's disease collaboration
Read More
Peregrine licensee begins phase I trial with TNT cancer agent
Read More
New phase I trial studies L-annamycin in pediatric ALL and AML
Read More
CUV-1647 significantly delays onset of erythropoietic protoporphyria pain
Read More
Development of AOD-9604 in obesity terminated following phase IIb results
Read More
Antitumor activity following GVAX immunotherapy + ipilimumab
Read More
Incyte updates pipeline advances
Read More
Phase III findings for Cimzia in rheumatoid arthritis
Read More
CureDM reports diabetes preclinical milestones
Read More
Valeant files IND for Cesamet in chemotherapy-induced neuropathic pain
Read More
Rosiglitazone linked to increased incidence of fractures in female patients
Read More
Novel synthetic diazonamide A analogue shows promise in preclinical studies
Read More
Therapeutic potential for prolactin inhibition in postpartum cardiomyopathy
Read More
(-)-Epigallocatechin-3-gallate lipophilic analogue shows antidiabetic activity in vitro and in vivo
Read More
Roche suspends recruitment in phase II CERA study
Read More
Avastin recommended for approvals in Japan, E.U.
Read More
Approvable letter for Galvus
Read More
Vyvanse approved for ADHD
Read More
Xeloda recommended for E.U. approval for advanced gastric cancer
Read More
Sebivo recommended for approval in E.U. for chronic hepatitis B
Read More
Recent patents disclose novel antiinfective agents
Read More
Novel agents for HIV infection reported in recent patents
Read More